Nisoldipine | Licensing, EU CTD Dossiers, Formulation Listed Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Nisoldipine
Listed Dossiers

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Nisoldipine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 8 USDMF, 2 JDMF, 1 EU WC, 2 NDC API, 4 Listed Suppliers, $ API Reference Price

11 API Suppliers
8 USDMF
2 JDMF
1 EU WC
2 NDC API
4 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

19 FDF Dossiers, 16 FDA Orange Book, 1 Europe, 2 Listed Dossiers

19 FDF Dossiers
16 FDA Orange Book
1 Europe
2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 17MG, TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 34MG, TABLET, EXTENDED RELEASE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 8.5MG

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 17MG
TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 34MG
TABLET, EXTENDED RELEASE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 8.5MG

RELATED EXCIPIENT COMPANIES

2 Evonik, 2 Seqens, 3 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 11 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 8 Ideal Cures Pvt Ltd, 28 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 3 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

50 Coating Systems & Additives, 38 Fillers, Diluents & Binders, 29 Controlled & Modified Release, 16 Direct Compression, 15 Granulation, 13 Solubilizers, 12 Lubricants & Glidants, 9 Film Formers & Plasticizers, 9 Co-Processed Excipients, 8 Topical, 8 Thickeners and Stabilizers, 5 Parenteral, 5 Empty Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 3 Disintegrants & Superdisintegrants, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers, 1 Chewable & Orodispersible Aids

50 Coating Systems & Additives
38 Fillers, Diluents & Binders
29 Controlled & Modified Release
16 Direct Compression
15 Granulation
13 Solubilizers
12 Lubricants & Glidants
9 Film Formers & Plasticizers
9 Co-Processed Excipients
8 Topical
8 Thickeners and Stabilizers
5 Parenteral
5 Empty Capsules
4 API Stability Enhancers
4 Taste Masking
4 Coloring Agents
4 Emulsifying Agents
4 Vegetarian Capsules
3 Disintegrants & Superdisintegrants
1 Surfactant & Foaming Agents
1 Rheology Modifiers
1 Chewable & Orodispersible Aids

DIGITAL CONTENT

1 NEWS #PharmaBuzz

1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 1 Finished Drug Prices

2 US Medicaid Prescriptions
1 Finished Drug Prices

REF. STANDARDS & IMPURITIES

5 Others

5 Others

$ API Ref.Price (USD/KG) : 2,758 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2Hanlim Pharmaceutical

filter Active Ingredients Reset all filters

2 All

01 2Nisoldipine

filter Dosage Reset all filters

2 All

01 2TABLET

filter Dosage Strength Reset all filters

2 All

01 110MG

02 15MG

filter Country Reset all filters

2 All

01 2South Korea

List of Suppliers

Product Main Page

01

Hanlim Pharmaceutical

2024 ACI Convention

Not Confirmed

Hanlim Pharmaceutical

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Generic

Registration Country : South Korea

Nisoldipine

Brand Name : NISOLDIN

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 60T, 300T

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

Portfolio PDF

Product Web Link

Digital Content

01

Hanlim Pharmaceutical

2024 ACI Convention

Not Confirmed

Hanlim Pharmaceutical

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging : 60T, 300T

Regulatory Info : Generic

Nisoldipine

Dosage : TABLET

Dosage Strength : 5MG

Brand Name : NISOLDIN

Approval Date :

Application Number :

Registration Country : South Korea

Portfolio PDF

Product Web Link

Digital Content

02

Hanlim Pharmaceutical

2024 ACI Convention

Not Confirmed

Hanlim Pharmaceutical

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Generic

Registration Country : South Korea

Nisoldipine

Brand Name : NISOLDIN

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 60T, 300T

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

Portfolio PDF

Product Web Link

Digital Content

02

Hanlim Pharmaceutical

2024 ACI Convention

Not Confirmed

Hanlim Pharmaceutical

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Packaging : 60T, 300T

Regulatory Info : Generic

Nisoldipine

Dosage : TABLET

Dosage Strength : 10MG

Brand Name : NISOLDIN

Approval Date :

Application Number :

Registration Country : South Korea

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?